ELL
RNA polymerase II elongation factor ELL · P55199 · ELL on Sugi Atlas →
0 patent compounds predicted against ELL, 0 high-confidence (nearest known ligand ≥ 0.5)
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to ELL by text similarity (a relevance ranking, not an exhaustive list)
Related proteins — ESM-2 sequence neighbours (a ELL binder may also engage these)
| Protein | Name | Similarity | |
|---|---|---|---|
| O08856 | — | 0.992 | O08856 → |
| Q3UKU1 | — | 0.984 | Q3UKU1 → |
| Q8TBN0 | — | 0.976 | Q8TBN0 → |
| Q66T02 | — | 0.975 | Q66T02 → |
| Q9Y2B5 | — | 0.974 | Q9Y2B5 → |
| P49797 | — | 0.974 | P49797 → |
| Q69Z89 | — | 0.974 | Q69Z89 → |
| Q9BUN5 | — | 0.973 | Q9BUN5 → |
| Q4R4I0 | — | 0.972 | Q4R4I0 → |
| P12755 | — | 0.972 | P12755 → |
| Q8C190 | — | 0.972 | Q8C190 → |
| A4D2P6 | — | 0.972 | A4D2P6 → |
| Q2KJ58 | — | 0.971 | Q2KJ58 → |
| O00472 | — | 0.971 | O00472 → |
| Q8N228 | — | 0.971 | Q8N228 → |
| Q86UK7 | — | 0.971 | Q86UK7 → |
| Q9TUG2 | — | 0.971 | Q9TUG2 → |
| Q9DD19 | — | 0.971 | Q9DD19 → |
| O77638 | — | 0.971 | O77638 → |
| Q8VDV3 | — | 0.970 | Q8VDV3 → |
| TERF2IP | Telomeric repeat-binding factor 2-interacting protein 1 | 0.970 | landscape → |
| Q9DC04 | — | 0.970 | Q9DC04 → |
| Q3UR85 | — | 0.970 | Q3UR85 → |
| Q5SNT2 | — | 0.970 | Q5SNT2 → |
| Q96JH8 | — | 0.969 | Q96JH8 → |
| Q8CEG5 | — | 0.969 | Q8CEG5 → |
| NFATC1 | Nuclear factor of activated T-cells, cytoplasmic 1 | 0.968 | landscape → |
| Q80YR4 | — | 0.968 | Q80YR4 → |
| PML | Protein PML | 0.967 | landscape → |
| MBD2 | Methyl-CpG-binding domain protein 2 | 0.967 | landscape → |